Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter
Public ClinicalTrials.gov record NCT00115791. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Tolerance and Efficacy Study of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate the effectiveness of RSD1235 compared with placebo, in the conversion of atrial fibrillation or atrial flutter to sinus rhythm.
Study identification
- NCT ID
- NCT00115791
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 276 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2004 (Type not available)
- Primary completion
- Jun 2005 (Actual)
- Completion
- Jun 2005 (Actual)
- Last update posted
- Apr 1, 2008
2004 – 2005
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigative Site | Birmingham | Alabama | 35213 | — |
| Investigative Site | Huntsville | Alabama | 35801 | — |
| Investigative Site | Gainesville | Florida | 32610 | — |
| Investigative Site | Orlando | Florida | 32803 | — |
| Investigative Site | Port Charlotte | Florida | 33952 | — |
| Investigative Site | Indianapolis | Indiana | 46202 | — |
| Investigative Site | Shreveport | Louisiana | 71103 | — |
| Investigative Site | Baltimore | Maryland | 21201 | — |
| Investigative Site | Lansing | Michigan | 48910 | — |
| Investigative Site | Petoskey | Michigan | 49770 | — |
| Investigative Site | Saint Paul | Minnesota | 55102 | — |
| Investigative Site | Tupelo | Mississippi | 38801 | — |
| Investigative Site | Holmdel | New Jersey | 07733 | — |
| Investigative Site | Cincinnati | Ohio | 45267 | — |
| Investigative Site | Amarillo | Texas | 79106 | — |
| Investigative Site | Houston | Texas | 77030 | — |
| Investigative Site | Richmond | Virginia | 23249 | — |
| Investigative Site | Tacoma | Washington | 98405 | — |
| Investigative Site | Marshfield | Wisconsin | 544449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00115791, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 1, 2008 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00115791 live on ClinicalTrials.gov.